PERSISTENCE AND OTHER TREATMENT PATTERNS AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB OR ADALIMUMAB

被引：0
|
作者：
Zhdanava, Maryia
Zhao, Ruizhi
Manceur, Ameur M.
Ding, Zhijie
Kachroo, Sumesh
Peddle, Mark
Lefebvre, Patrick
Pilon, Dominic
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1568
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumab
    Zhdanava, Maryia
    Zhao, Ruizhi
    Manceur, Ameur M.
    Ding, Zhijie
    Kachroo, Sumesh
    Holiday, Christopher
    Lefebvre, Patrick
    Pilon, Dominic
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08): : 907 - 916
  • [2] PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Pilon, Dominic
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S36 - S36
  • [3] PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Pilon, Dominic
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S45 - S46
  • [4] Treatment Persistence Among Bio-naive Patients with Crohn's Disease Initiated on Ustekinumab and Adalimumab
    Pilon, Dominic
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Zhdanava, Maryia
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S328 - S329
  • [5] Treatment persistence among bio-naive patients with Crohn's disease initiated on ustekinumab or adalimumab
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Muser, Erik
    Lefebvre, Patrick
    Holiday, Christopher
    Lafeuille, Marie-Helene
    Pilon, Dominic
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 533 - 543
  • [6] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S47 - S47
  • [7] SUPERIOR PERSISTENCE WHILE ON LABELED MAINTENANCE DOSE AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB COMPARED TO ADALIMUMAB
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Muser, Erik
    Pilon, Dominic
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S37 - S37
  • [8] PERSISTENCE AND DOSE TITRATION AMONG BIO-NAIVE PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB OR ADALIMUMAB
    Pilon, Dominic
    Ding, Zhijie
    Manceur, Ameur M.
    Zhdanava, Maryia
    Zhao, Ruizhi
    Holiday, Christopher
    Kachroo, Sumesh
    Lefebvre, Patrick
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S415 - S415
  • [9] Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naive Patients With Crohn's Disease
    Zhdanava, Maryia
    Ding, Zhijie
    Manceur, Ameur M.
    Kachroo, Sumesh
    Holiday, Christopher
    Zhao, Ruizhi
    Izanec, James
    Pilon, Dominic
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S571 - S572
  • [10] Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn's disease patients: a retrospective multicenter study
    Na, Ji Eun
    Park, Yong Eun
    Park, Jongha
    Kim, Tae-Oh
    Lee, Jong Hoon
    Park, Su Bum
    Kim, Soyoung
    Lee, Seung Bum
    [J]. BMC GASTROENTEROLOGY, 2024, 24 (01)
12345